<DOC>
	<DOCNO>NCT00318357</DOCNO>
	<brief_summary>The CARE-HF long-term follow-up trial evaluate effect cardiac resynchronization ( CR ) therapy mortality patient CARE-HF program additional 4 year follow-up . Investigators free choose whatever available treatment believe patient 's best interest .</brief_summary>
	<brief_title>CARE-HF LTFU : CArdiac REsynchronization Heart Failure Long-Term Follow-up</brief_title>
	<detailed_description>The CARE-HF study enrol 813 patient 82 center 12 European country ( Austria , Belgium , Denmark , Finland , France , Germany , Italy , Netherlands , Spain , Sweden , Switzerland , UK ) . All patient report alive May 2005 ask participate .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients participate CAREHF program report alive May 2005 Patients sign patient data release consent form Patients participated CAREHF program Patients exclusion criterion require local legislation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Cardiac Resynchronization therapy ( CRT )</keyword>
	<keyword>All-cause mortality</keyword>
	<keyword>Long-term follow-up</keyword>
</DOC>